Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosing Patterns With Regorafenib in Clinical Practice in Spain: A Retrospective Study.

NCT04920422 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04920422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04920422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosing Patterns With Regorafenib in Clinical Practice in Spain: A Retrospective Study.
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 15, 2021
Completion date
October 7, 2022
Enrollment
242 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer